PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1871187
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1871187
DNA-Based Customized Vitamin Formulations Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
The Global DNA-Based Customized Vitamin Formulations Market was valued at USD 520 million in 2024 and is estimated to grow at a CAGR of 16.4% to reach USD 2.4 Billion by 2034.
The growth is fueled by advancements in genetic testing technologies and rising consumer awareness of personalized health, driven in part by the prevalence of chronic diseases that benefit from tailored nutritional approaches. Although still a niche sector, it is expanding alongside the broader personalized nutrition market. Affordable and accessible genetic testing has attracted new consumers, while digital health infrastructure growth in emerging regions offers untapped potential. End-to-end personalized nutrition platforms, from genetic testing to supplement delivery and health tracking, create premium offerings and cross-selling opportunities. With millions of adults consuming dietary supplements globally, the market has considerable room for expansion, supported by wellness ecosystems that integrate genetic insights into preventive health strategies, nutrition planning, and overall lifestyle optimization.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $520 Million |
| Forecast Value | $2.4 Billion |
| CAGR | 16.4% |
The single-nucleotide polymorphism (SNP) testing segment held a 57.8% share and is projected to grow at a CAGR of 14.9% through 2034. SNP analysis is cost-effective, clinically validated, and highly precise in linking genetic variants to nutrient metabolism. With mature technology, growing variant panels, and improved interpretation methods, SNP-based approaches continue to gain traction in consumer-focused nutrition markets.
The vitamin deficiency assessment segment held 43.5% share in 2024 and is expected to grow at a CAGR of 16.1% from 2025 to 2034. Assessing vitamin deficiencies provides critical insights into an individual's genetic predisposition for nutrient absorption and utilization, forming the backbone of preventive health protocols. Rising awareness of the genetic factors influencing vitamin status drives adoption among consumers and healthcare providers seeking predictive and accurate nutrition planning.
North America DNA-Based Customized Vitamin Formulations Market held a 44.2% share in 2024. The region benefits from advanced healthcare infrastructure, high consumer awareness, and a supportive regulatory environment. Acceptance of direct-to-consumer genetic testing has driven adoption, and preventive health approaches are increasingly integrated into clinical practice. Strong venture capital funding for personalized nutrition startups further accelerates market growth.
Key companies in the Global DNA-Based Customized Vitamin Formulations Market include Persona Nutrition, Rootine, Viome Life Sciences, GenoPalate, Habit (Campbell Soup Company), Nutrigenomix Inc., 23andMe Inc., Care/of, Season Health, InsideTracker, DNAfit (Prenetics), Bioniq, Mapmygenome, Xcode Life, and Avesthagen. Companies in the DNA-Based Customized Vitamin Formulations Market focus on expanding product offerings, integrating advanced genetic testing, and leveraging AI-driven nutrition insights. Partnerships with healthcare providers, fitness platforms, and wellness ecosystems improve credibility and customer access. Direct-to-consumer sales models and digital platforms enhance user engagement and convenience. Marketing efforts emphasize personalization, preventive health benefits, and scientifically validated recommendations to build trust.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope and definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
- 1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.6 Forecast model
- 1.7 Research assumptions and limitations
Chapter 2 Executive Summary
- 2.1 Industry 3600 synopsis
- 2.2 Key market trends
- 2.2.1 Regional
- 2.2.2 Technology type
- 2.2.3 Application
- 2.2.4 Distribution channel
- 2.3 TAM Analysis, 2025-2034
- 2.4 CXO perspectives: Strategic imperatives
- 2.4.1 Executive decision points
- 2.4.2 Critical success factors
- 2.5 Future Outlook and Strategic Recommendations
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Supplier landscape
- 3.1.2 Profit margin
- 3.1.3 Value addition at each stage
- 3.1.4 Factor affecting the value chain
- 3.1.5 Disruptions
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Rising chronic disease prevalence
- 3.2.1.2 Consumer health consciousness growth
- 3.2.1.3 Technology advancement & cost reduction
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 Regulatory complexity & compliance requirements
- 3.2.2.2 Limited clinical validation
- 3.2.3 Market opportunities
- 3.2.3.1 AI & machine learning integration
- 3.2.3.2 Wearable device convergence
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East & Africa
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
- 3.7 Price trends
- 3.7.1 By region
- 3.7.2 By technology type
- 3.8 Future market trends
- 3.9 Technology and Innovation landscape
- 3.9.1 Current technological trends
- 3.9.2 Emerging technologies
- 3.10 Patent Landscape
- 3.11 Trade statistics (HS code) ( Note: the trade statistics will be provided for key countries only)
- 3.11.1 Major importing countries
- 3.11.2 Major exporting countries
- 3.12 Sustainability and environmental aspects
- 3.12.1 Sustainable practices
- 3.12.2 Waste reduction strategies
- 3.12.3 Energy efficiency in production
- 3.12.4 Eco-friendly initiatives
- 3.13 Carbon footprint consideration
Chapter 4 Competitive Landscape, 2024
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.2.1 By region
- 4.2.1.1 North America
- 4.2.1.2 Europe
- 4.2.1.3 Asia Pacific
- 4.2.1.4 LATAM
- 4.2.1.5 MEA
- 4.2.1 By region
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New Product Launches
- 4.6.4 Expansion Plans
Chapter 5 Market Estimates and Forecast, By Technology Type, 2021-2034 (USD Million) (Kilo Tons)
- 5.1 Key trends
- 5.2 Single nucleotide polymorphism (SNP)
- 5.3 Next-generation sequencing (NGS)
- 5.4 Microarray technology
- 5.5 Real-time PCR
Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 (USD Million) (Kilo Tons)
- 6.1 Key trends
- 6.2 Vitamin deficiency assessment
- 6.3 Metabolic health optimization
- 6.4 Athletic performance enhancement
- 6.5 Aging & longevity support
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021-2034 (USD Million) (Kilo Tons)
- 7.1 Key trends
- 7.2 Direct-to-consumer (DTC)
- 7.3 Healthcare providers
- 7.4 Retail pharmacies
- 7.5 Specialty nutrition stores
Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 (USD Million) (Kilo Tons)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
- 9.1 23andMe Inc.
- 9.2 Persona Nutrition
- 9.3 Viome Life Sciences
- 9.4 DNAfit (Prenetics)
- 9.5 Nutrigenomix Inc.
- 9.6 Rootine
- 9.7 InsideTracker
- 9.8 GenoPalate
- 9.9 Care/of
- 9.10 Habit (Campbell Soup Company)
- 9.11 Season Health
- 9.12 Bioniq
- 9.13 Xcode Life
- 9.14 Mapmygenome
- 9.15 Avesthagen
